CORTEXA
← Browse
openalexFrontiers in Cell and Developmental Biology2026-07-24Cited by 0

VEA-net: vascular enhancement attention with dual-backbone multi-task learning for comprehensive ROP management across multi-center datasets

Yuehua Chen, Jiajun Wan, Tian Zhang, Zhijiang Wan, Jin Hong, Youpeng Jin

Background Retinopathy of Prematurity (ROP) is a vasoproliferative retinal disorder and a major cause of childhood blindness worldwide. Clinical ROP management involves three correlated tasks: Plus disease detection, stage classification, and treatment decision-making. Although deep learning (DL) has shown promise for automated ROP management, several challenges remain: (1) retinal vascular morphology is central to Plus disease assessment, but DL-based vascular feature modeling is not always explicitly integrated into unified end-to-end multi-task frameworks; (2) Plus disease detection, stage classification, and treatment decision-making are clinically related, yet they are often modeled as separate tasks; and (3) model robustness may be affected by class imbalance and domain shifts across heterogeneous datasets. Methods We propose VEA-Net, a novel dual-backbone multi-task learning framework that addresses these challenges through three core components: (1) We introduce the Vascular Enhancement Attention (VEA) module, which explicitly models and enhances vascular features through multi-scale convolutions, directional selective filtering, and dual attention mechanisms. (2) We develop a hierarchical multi-task learning architecture that jointly optimizes Plus detection, stage classification, and treatment decision-making while leveraging task correlations through hierarchical consistency losses. (3) We implement a dual-domain adaptation strategy combining Domain-Adversarial Neural Networks (DANN) with Maximum Mean Discrepancy (MMD) to learn domain-invariant representations across heterogeneous data sources. Results We validate VEA-Net on three public ROP datasets (FARFUM-ROP, Ostrava, and A-Fundus), comprising 8,636 retinal images from different geographic regions and imaging settings. Using subject-level 10-fold cross-validation with Group K-Fold splitting, our model achieves test AUROC of 91.76% <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="m1"> <mml:mrow> <mml:mo>±</mml:mo> </mml:mrow> </mml:math> 4.16% for Plus detection, 88.26% <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="m2"> <mml:mrow> <mml:mo>±</mml:mo> </mml:mrow> </mml:math> 4.61% for stage classification, and 66.81% <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="m3"> <mml:mrow> <mml:mo>±</mml:mo> </mml:mrow> </mml:math> 15.87% for treatment decision-making. Conclusion VEA-Net provides a unified framework for image-based ROP management by integrating vascular enhancement, hierarchical multi-task learning, and domain adaptation. The model supports Plus detection, stage classification, and auxiliary treatment decision support within a single architecture. The results indicate VEA-Net can learn robust representations across heterogeneous public datasets, and potential for improving ROP management efficiency.

View free PDFSource page

Related papers

openalexFrontiers in Cell and Developmental Biology2026-07-24

Dynamic tumor microenvironment remodeling in cancer therapy resistance: molecular mechanisms and translational opportunities

Xiaoying Li, Shuang Dai, Dan Cao, Hou Wt

Therapeutic resistance remains a major obstacle in solid tumor management, arising not only from tumor cell-intrinsic alterations but also from dynamic remodeling of the tumor microenvironment (TME). Therapy-induced changes in stromal and immune cells, extracellular matrix (ECM)…

View free PDFSource page
openalexFrontiers in Cell and Developmental Biology2026-07-24

Editorial: Metabolic pathways in early embryogenesis: mechanisms and implications

Marcella Pecora Milazzotto, Marcos Roberto Chiaratti, Jo Leroy, Camila Bruna de Lima

contributions assembled in this Research Topic, "Metabolic Pathways in Early Embryogenesis: Mechanisms and Implications," collectively underscore that metabolism is not a passive background process but a primary driver and regulator of early development, with implications for imp…

View free PDFSource page
openalexFrontiers in Cell and Developmental Biology2026-07-23

MEOX2: a homeobox transcription factor with multifaceted biological functions and broad disease associations

Yi Liu, Minming Yi, Chunrong Tang, Taiqiang Wang, X J Li

The mesenchymal homeobox transcription factor MEOX2 is recognized for its roles in development and homeostasis, but the full landscape of its complex and often contradictory functions in human diseases, along with its potential unifying regulatory logic, remains to be systematica…

View free PDFSource page
openalexFrontiers in Cell and Developmental Biology2026-07-23

Ubiquitin-specific protease 25: a new regulator for cardiovascular and cerebrovascular diseases

Yingchun Shao, Shan Jiang, LI Zh, Fusheng Sun

Ubiquitin-specific protease 25 (USP25), a pivotal deubiquitinating enzyme, has attracted increasing attention in cardiovascular and cerebrovascular research due to its regulatory function in maintaining ubiquitination homeostasis. Considerable advances have been achieved in eluci…

View free PDFSource page
crossrefFrontiers in Cell and Developmental Biology2026-07-09

Machine learning-based models for predicting the efficacy and safety of recombinant human interleukin-11 in the treatment of cancer therapy-induced thrombocytopenia: exploration and preliminary validation from a multicenter retrospective study

Yingmei Wen, Jinxiong Xia, Yi Dong, Zheming Liu, Shuyang Yu, Yuanyuan Wang, et al.

Introduction Cancer therapy-induced thrombocytopenia (CTIT) is a common hematologic toxicity associated with anti-tumor treatment. Recombinant human interleukin-11 (rhIL-11), as a thrombopoietic agent, is widely used in clinical practice. However, its efficacy and safety exhibit…

View free PDFSource page